Receive regular headline summaries whenever high-quality news is generated for this page. We'll never share your email address with others.
|3/31/2020||Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies
... distinguished syndicate to advance our platform and investigational product candidates toward the clinic for patients in need.” The company's technology was licensed from Lonza and Massachusetts Eye and Ear. It was developed at the Grousbeck Gene Therapy Center and further advanced under a sponsored research agreement with Lonza led by ...